Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Uncategorized

New Jersey: The Life Sciences Commercialization Hub

Jon Crowley, chairman and CEO of Amicus Therapeutics, is the keynote speaker.  The event is Dec. 10 in Florham Park, 10:30 a.m. to 2 p.m. Details are posted here.

2018 Regional Academic Drug Discovery Conference

The N.J. Academic Drug Discovery Consortium second annual meeting will be held Nov. 15 at Rutgers University in Piscataway. Read more and register here.

 

Seventh annual National Manufacturing Day event October 5 in Somerset

The seventh annual National Manufacturing Day event, sponsored by the New Jersey Manufacturing Extension Program Inc., will be held at The Marigold in Somerset on October 5  from 7:30 a.m. to 2:30 p.m. Read more and register here.

New Jersey’s Connected Economy: Measuring the Ripple Effect of Economic Policy

This in-depth new report from NJPRO, the New Jersey Policy Research Organization, is relevant to every industry in New Jersey, elected officials, and citizens.

Vocational Schools to Share $3M to Partner with Businesses

From New Jersey Business magazine

Seven school districts will share $3 million in grants to bolster partnerships between business and county vocational-technical schools, the New Jersey Department of Education (DOE) announced May 8.

The $3 million is part of the County Vocational School District Partnership Grant Program funded by the state. It supports county vocational-technical school districts that partner with business and industry, comprehensive K-12 school districts, and post-secondary institutions to expand high school students’ access and participation in career and technical education (CTE) programs.

Read more here.

New Rutgers App Seeks to Reduce Infant Mortality

From Rutgers Today

The SIDS Info app developed by Rutgers medical experts puts safe sleep recommendations in the hands of health care providers and new parents

Peter LaMont’s second child will be born next month, but the last time he put an infant to bed was 16 years ago. So, the Bridgewater father turned to the SIDS Center of New Jersey’s new SIDS Info app to catch up on safe sleep recommendations for babies.

The app was launched last month by the SIDS Center of New Jersey, which is based at Rutgers Robert Wood Johnson Medical School and Hackensack Meridian Health.  Read more here.

Eric LeGrand to Speak March 20 at Rutgers Medical Device Development Center

Eric LeGrand, the former Rutgers football player who has become a nationally recognized advocate for research on spinal cord injuries, will speak at a March 20 seminar sponsored by the Health Care Institute of New Jersey and Rutgers’ Medical Device Development Center.

Eris LeGrand, former Rutgers football player

 

 

 

 

 

The event will be held from 5:30-7 p.m. in Rutgers’ Fiber Optics Auditorium in Piscataway. There is no cost to attend but registration is required here: .

Trump Still Has Not Named Top Science Adviser in Eight Months Since Inauguration

President Donald Trump

Washington, DC, October 9, 2017 — Celeste Katz reports in Newsweek that President Donald Trump and Ivanka Trump, his daughter-adviser, have been going all out to tout the administration’s commitment to “high-quality STEM and computer science education” as a means of boosting the U.S. economy.

However, Katz reports, President Trump has yet to choose a top science adviser, who would play a crucial role in turning the White House horn-tooting into reality.

The White House Office of Science and Technology (OSTP) has been without a boss for the longest stretch since its establishment in 1976, a former longtime member told Newsweek. Continue reading

New Jersey Innovation Institute Introduces Two Groundbreaking Biopharmaceutical Centers

Newark, NJ, June 24, 2017 — Companies in every sector are realizing that manufacturing matters.  For the biopharmaceutical industry, innovation is not about reducing unit part costs; instead, process technology is a strategic tool to reduce time to market, ensure consistent product quality and streamline regulatory approval.

As rapidly as science is advancing drug discovery, so too, must production technology keep pace.  But where will such innovation happen?

The New Jersey Innovation Institute (NJII) is answering this question. Continue reading

Opinion: Labor Leader Greg Lalevee on ‘Workers Win When Jersey Drug Companies Innovate’

Greg Lalevee

Springfield, NJ, June 21, 2017The Record/NorthJersey.com on June 15 published the following opinion piece by Greg Lalevee, Business Manager, the International Union of Operating Engineers Local 825:

New Jersey’s nickname, “Medicine Chest of the World,” is backed up by the numbers.

Our state is home to more than 3,000 life sciences establishments.  Thirteen of the world’s top 20 biopharmaceutical companies have made the Garden State their U.S. headquarters.

These firms are innovating and saving lives every day — and they couldn’t do it without help from supportive government policies and New Jersey’s well-trained and talented union workforce. Continue reading